Migraine and Hidden Hearing Loss: OAE Study

Nearly two-thirds of patients with chronic migraine show measurable, subclinical abnormalities in their inner ear and auditory nerve function. This key finding, from a detailed study by neurologists at Assiut University in Egypt, provides objective evidence that the auditory system is frequently involved in migraine pathology. The research offers a physiological link for why individuals with migraine may be more prone to conditions like tinnitus and hyperacusis, even when their standard hearing test appears normal.

Mapping the Auditory System in Migraine Patients

Led by Dr. Sherifa A. Hamed, the research team compared 58 patients diagnosed with migraine to 40 healthy control subjects. To get a comprehensive picture of auditory health, they moved beyond the standard “beep” hearing test. They employed a battery of electrophysiological assessments designed to probe different parts of the hearing pathway.

The tests included Transient and Distortion Product Otoacoustic Emissions (TOAEs & DPOAEs). These measure sounds emitted by the healthy outer hair cells of the inner ear (cochlea), providing a direct snapshot of cochlear function. They also used Auditory Brainstem Response (ABR) testing, which records the electrical activity of the auditory nerve and brainstem in response to sound. By performing ABR at both high and low repetition rates, the researchers could assess how well the auditory pathways handled a faster, more demanding signal flow.

Clear Evidence of Cochlear and Neural Compromise

The results were striking. While routine audiometry was normal, the more sensitive tests revealed widespread issues.

Otoacoustic emissions were significantly lower in migraine patients compared to controls. The amplitudes of TOAEs were reduced at 1 kHz, 3 kHz, and 4 kHz frequencies in one or both ears. DPOAEs were also lower across multiple frequencies, from 1 kHz to 5 kHz. This pattern indicates a subclinical dysfunction of the cochlea’s outer hair cells—the delicate sensory cells that amplify sound and are highly vulnerable to reduced blood flow and metabolic stress.

The ABR results pointed to problems further along the auditory pathway. Patients showed prolonged latency of wave III (generated in the brainstem) and a longer I-V interpeak latency (the time it takes a signal to travel from the auditory nerve to the midbrain) when sounds were presented at high repetition rates. This suggests that the speed and efficiency of signal transmission through the auditory brainstem are impaired in migraine, particularly under conditions that mimic processing a rapid stream of sound.

Perhaps most telling were the correlations. The study found that a higher frequency of migraine attacks and a longer history of the disease were associated with poorer OAE amplitudes and longer ABR latencies. This points to a cumulative impact of migraine on the auditory system.

Implications: Connecting Migraine to Hearing Disorders

These findings have direct practical implications for understanding the overlap between migraine and auditory conditions. The observed cochlear dysfunction provides a plausible explanation for the high prevalence of tinnitus (phantom ringing) and hyperacusis (sound sensitivity) in migraine patients. Even subtle damage to outer hair cells can disrupt the delicate balance of sound processing, leading to these symptoms. The study adds objective biological evidence to the established clinical link, which we explore in more detail in Migraine’s Link to Hearing and Sound Disorders.

The proposed mechanism by Hamed and colleagues is vascular. Migraine is known to involve changes in blood vessel diameter and function. The inner ear and auditory nerve are supplied by fine arteries with little backup circulation, making them susceptible to reductions in blood supply. Repeated migraine attacks could lead to a form of cumulative micro-trauma or ischemic compromise to these delicate structures.

This vascular hypothesis opens avenues for potential future therapies. If blood flow is a key issue, treatments aimed at improving cochlear and neural circulation or protecting these tissues from ischemic damage could be beneficial. Research into novel delivery systems, such as the nanocarriers being developed for hearing health, could one day play a role in targeting therapeutics to the inner ear.

A New Perspective for Patients and Clinicians

For patients with migraine who experience tinnitus, sound sensitivity, or a feeling of “fullness” in their ears, this study validates their experience as having a genuine physiological basis. It argues for a more integrated approach to care. Neurologists and headache specialists should consider inquiring about auditory symptoms, while audiologists and otolaryngologists should view a history of migraine as a significant risk factor for subtle auditory pathway dysfunction.

Monitoring these subclinical changes over time may even provide biomarkers for migraine progression or treatment efficacy. The research by Hamed’s team, published in the American Journal of Otolaryngology (PMID: 22133970), strengthens the case that migraine is not just a headache disorder, but a complex neurological condition with wide-ranging effects, including on our fundamental sense of hearing. Understanding this connection is a critical step toward better management and more comprehensive treatment strategies for affected individuals.